Thank you for your participation!
Joseph B. Martin Conference Center
at Harvard Medical School
77 Avenue Louis Pasteur, Boston, MA 02115
About the Conference
The First Stop for Growing Your
The 15th Annual Trans-Pacific Health Sciences Dialogue is a meeting for biopharmaceutical industry executives and business development executives who want to accelerate, explore and develop collaborations and partnerships with their counterparts in the most important Trans-Pacific health care markets including Japan, China, South Korea and North America.
This is a must-attend meeting for executives who have, or want to develop, a Trans-Pacific strategy. The event has developed a well-earned reputation as the best place for biopharma companies seeking to forge Trans-Pacific ventures to start exploring their options. Attendees come away with a broad overview and insights they simply will not get in other meetings.
Take a look at some photos from the 2016 Trans-Pacific Health Sciences Dialogue!
Industry News from FiercePharmaAsia
- FDA holds off on job cuts, assures workers Congress will authorize user feesThousands of FDA employees will get a reprieve instead of pink slips next week, as new FDA Commissioner Scott Gottlieb gave them encouraging news about the reauthorization of FDA user fees and their job prospects.
- AstraZeneca, spurred by China’s respiratory demands, expands Australian plantAir pollution in big cities and a high smoking rate has led to China’s growing demands for respiratory treatments, and AstraZeneca is reacting by pouring about $77 million into production expansion at its Sydney, Australia, plant.
Who Should Attend
The Trans-Pacific Health Sciences Dialogue is an event for biopharmaceutical executives, KOLs, select industry advisors and members of the financial community with a strategic interest in Trans-Pacific collaboration or investment.